Literature DB >> 32071080

Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cells.

Jeff Klomp1, James Hyun1, Jennifer E Klomp1, Kostandin Pajcini1, Jalees Rehman2,3, Asrar B Malik4.   

Abstract

Endothelial cells (ECs) lining the vasculature of vertebrates respond to low oxygen (hypoxia) by maintaining vascular homeostasis and initiating adaptive growth of new vasculature through angiogenesis. Previous studies have uncovered the molecular underpinnings of the hypoxic response in ECs; however, there is a need for comprehensive temporal analysis of the transcriptome during hypoxia. Here, we sought to investigate the early transcriptional programs of hypoxic ECs by using RNA-Seq of primary cultured human umbilical vein ECs exposed to progressively increasing severity and duration of hypoxia. We observed that hypoxia modulates the expression levels of approximately one-third of the EC transcriptome. Intriguingly, expression of the gene encoding the developmental transcription factor SOX7 (SRY-box transcription factor 7) rapidly and transiently increased during hypoxia. Transcriptomic and functional analyses of ECs following SOX7 depletion established its critical role in regulating hypoxia-induced angiogenesis. We also observed that depletion of the hypoxia-inducible factor (HIF) genes, HIF1A (encoding HIF-1α) and endothelial PAS domain protein 1 (EPAS1 encoding HIF-2α), inhibited both distinct and overlapping transcriptional programs. Our results indicated a role for HIF-1α in down-regulating mitochondrial metabolism while concomitantly up-regulating glycolytic genes, whereas HIF-2α primarily up-regulated the angiogenesis transcriptional program. These results identify the concentration and time dependence of the endothelial transcriptomic response to hypoxia and an early key role for SOX7 in mediating angiogenesis.
© 2020 Klomp et al.

Entities:  

Keywords:  angiogenesis; endothelial cell; hypoxia; transcriptomics; vascular

Mesh:

Substances:

Year:  2020        PMID: 32071080      PMCID: PMC7152765          DOI: 10.1074/jbc.RA119.011822

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

3.  Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice.

Authors:  Toshiyasu Matsui; Masami Kanai-Azuma; Kenshiro Hara; Shogo Matoba; Ryuji Hiramatsu; Hayato Kawakami; Masamichi Kurohmaru; Peter Koopman; Yoshiakira Kanai
Journal:  J Cell Sci       Date:  2006-08-08       Impact factor: 5.285

4.  SOX7 regulates the expression of VE-cadherin in the haemogenic endothelium at the onset of haematopoietic development.

Authors:  Guilherme Costa; Andrzej Mazan; Arnaud Gandillet; Stella Pearson; Georges Lacaud; Valerie Kouskoff
Journal:  Development       Date:  2012-05       Impact factor: 6.868

5.  Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl 2 treatment.

Authors:  Nadezhda Zhigalova; Artem Artemov; Alexander Mazur; Egor Prokhortchouk
Journal:  F1000Res       Date:  2015-12-30

Review 6.  Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena.

Authors:  Jing-Wen Shih; Hsing-Jien Kung
Journal:  J Biomed Sci       Date:  2017-08-08       Impact factor: 8.410

7.  SOX7 expression is critically required in FLK1-expressing cells for vasculogenesis and angiogenesis during mouse embryonic development.

Authors:  Andrew J Lilly; Andrzej Mazan; Daryl A Scott; Georges Lacaud; Valerie Kouskoff
Journal:  Mech Dev       Date:  2017-05-31       Impact factor: 1.882

8.  Inherent DNA-binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin.

Authors:  James A Smythies; Min Sun; Norma Masson; Rafik Salama; Peter D Simpson; Elizabeth Murray; Viviana Neumann; Matthew E Cockman; Hani Choudhry; Peter J Ratcliffe; David R Mole
Journal:  EMBO Rep       Date:  2018-11-14       Impact factor: 8.807

Review 9.  Transcriptional regulation by hypoxia inducible factors.

Authors:  Veronica L Dengler; Matthew Galbraith; Joaquín M Espinosa
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

10.  The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches.

Authors:  Marco Mineo; Franz Ricklefs; Arun K Rooj; Shawn M Lyons; Pavel Ivanov; Khairul I Ansari; Ichiro Nakano; E Antonio Chiocca; Jakub Godlewski; Agnieszka Bronisz
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

View more
  5 in total

Review 1.  Cancer-Induced Metabolic Rewiring of Tumor Endothelial Cells.

Authors:  Jacopo Lidonnici; Massimo M Santoro; Roxana E Oberkersch
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  Hypoxia classifier for transcriptome datasets.

Authors:  Laura Puente-Santamaría; Lucia Sanchez-Gonzalez; Ricardo Ramos-Ruiz; Luis Del Peso
Journal:  BMC Bioinformatics       Date:  2022-05-31       Impact factor: 3.307

Review 3.  Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter.

Authors:  Tord Hompland; Christina Sæten Fjeldbo; Heidi Lyng
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

4.  Epigenetic response to hyperoxia in the neonatal lung is sexually dimorphic.

Authors:  Cristian Coarfa; Sandra L Grimm; Tiffany Katz; Yuhao Zhang; Rahul K Jangid; Cheryl L Walker; Bhagavatula Moorthy; Krithika Lingappan
Journal:  Redox Biol       Date:  2020-09-11       Impact factor: 11.799

5.  Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization.

Authors:  Zhiyong Xu; Chunyi Guo; Qiaoli Ye; Yueli Shi; Yihui Sun; Jie Zhang; Jiaqi Huang; Yizhou Huang; Chunlai Zeng; Xue Zhang; Yuehai Ke; Hongqiang Cheng
Journal:  Nat Commun       Date:  2021-11-02       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.